Mirati Therapeutics Inc. (MRTX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
5:33 pm
Sale
2021-12-3113GMIRATI THERAPEUTICS INC
MRTX
PERCEPTIVE ADVISORS LLC3,283,783
5.900%
-409,733decrease
(-11.09%)
Filing
History
2022-02-11
10:01 am
Purchase
2021-12-3113GMIRATI THERAPEUTICS INC
MRTX
Avoro Capital Advisors LLC5,075,000
9.200%
540,000increase
(+11.91%)
Filing
History
2022-02-10
08:27 am
Purchase
2021-12-3113GMIRATI THERAPEUTICS INC
MRTX
VANGUARD GROUP INC4,438,977
8.040%
406,739increase
(+10.09%)
Filing
History
2022-02-09
09:22 am
Sale
2022-02-0813GMIRATI THERAPEUTICS INC
MRTX
FMR LLC2,735,803
4.954%
-42,554decrease
(-1.53%)
Filing
History
2022-02-04
09:21 am
Purchase
2021-12-3113GMIRATI THERAPEUTICS INC
MRTX
Wellington Management Group LLP3,145,632
5.700%
3,145,632increase
(New Position)
Filing
History
2022-01-10
12:54 pm
Sale
2021-12-3113GMIRATI THERAPEUTICS INC
MRTX
BlackRock, Inc.
BLK
2,756,675
4.990%
-1,523,737decrease
(-35.60%)
Filing
History
Goto Prev, 0, 1